Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/1993
03/16/1993CA1314553C Bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same
03/14/1993CA2076257A1 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives
03/11/1993CA2077213A1 Bicyclic carboxylic acid derivatives
03/10/1993EP0531078A1 (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form
03/10/1993EP0530907A1 Indoles as inhibitors of HIV reverse transcriptase
03/10/1993EP0530888A1 Fluoromacrolides having immunosuppressive activity
03/10/1993EP0530639A1 Quinolylmethoxy-phenylacetamides substituted by a heterocycle as lipoxygenase inhibitors
03/10/1993EP0530446A2 Use of sulfur containing carboxylic acids for combatting pathophysiologic excitatory disorders and related diseases as well as allergic diseases and their preparation as medicament
03/10/1993EP0530207A1 Imidazopyridine paf antagonists
03/10/1993EP0525002A4 2(5h)-furanones substituted in the 3 position, as ca?2+ channel antagonists and anti-inflammatory agents
03/10/1993EP0346460B1 Purine derivatives having pharmacological action
03/10/1993CN1069732A 1,7-Condensed 2-(piperazinealkyl)-indole derivatives and process for preparing same and intermediate and pharmaceutical containing same
03/10/1993CA2077732A1 Heterocyclic derivatives
03/10/1993CA2077638A1 N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n- alkynylheteroarylmacrolides having immunosuppressive activity
03/10/1993CA2077331A1 O-heteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosuppressive activity
03/10/1993CA2074419A1 1,4-dihydropyridines with paf-antagonistic activity
03/09/1993US5192790 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis
03/09/1993US5192773 Immunosuppressive compounds
03/09/1993US5192771 (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents
03/09/1993US5192746 Cyclic cell adhesion modulation compounds
03/09/1993CA1314290C Hydroxamic acids of 7-oxabicycloheptane substituted ethers
03/09/1993CA1314211C Agent for reducing nephrotoxicity caused by cyclosporin administration
03/07/1993CA2077465A1 Heterocyclically substituted quinolylmethoxy-phenylacetamides
03/07/1993CA2077283A1 Inhibitors of hiv reverse transcriptase
03/06/1993WO1993004679A1 Macrocyclic immunomodulators
03/06/1993CA2103453A1 Macrocyclic immunomodulators
03/06/1993CA2076722A1 Pharmaceutical agents
03/04/1993WO1993004174A1 Ryegrass pollen allergen
03/04/1993WO1993004173A1 Immunoglobulin variants for specific fc epsilon receptors
03/04/1993WO1993004056A1 New leukotriene-b4 antagonists, methods of preparing them and their use as drugs
03/04/1993WO1993004043A1 Anti-hiv (aids) agents
03/04/1993WO1993003762A1 Immunostimulation
03/04/1993WO1993003760A1 Sirs vaccine and diagnosis method
03/04/1993WO1993003746A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives
03/04/1993WO1993003735A1 Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
03/04/1993WO1993003668A1 Cardiac output probe assembly
03/04/1993DE4128690A1 Bicyclische sulfone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel Bicyclic sulfones, process for their production and containing the same drug
03/04/1993CA2115581A1 Anti-hiv (aids) agents
03/04/1993CA2115424A1 Immunostimulation
03/04/1993CA2115270A1 The use of the peptidoglycan monomer (pgm), its n-acyl derivatives, and its metal complexes in the preparation of medicaments for the correction of the immunosuppressive and hepatosuppressive states of the organism
03/04/1993CA2114951A1 New leukotriene-b antagonists, methods of preparing them and their use as drugs
03/03/1993EP0529749A1 Leukotriene-B4-antagonists, method for their preparation, and their use as medicaments
03/03/1993EP0529500A1 Medicament for the treatment of rejection reactions during organ transplantations
03/03/1993EP0529452A2 1,7-Condensed 2-(piperazinoalkyl)indol derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
03/03/1993EP0529450A1 Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors
03/03/1993EP0529033A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
03/03/1993EP0529023A1 Therapeutically useful peptides and peptides fragments
03/03/1993EP0529007A1 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION
03/03/1993EP0528957A1 Five-membered ring alkanoic acid leukotriene antagonists
03/03/1993EP0528926A1 Soluble peptide analogues containing binding sites
03/03/1993EP0528835A1 Cyclic peptides and their use
03/03/1993EP0495919A4 Protection from shock subsequent to injury by double-stranded rnas
03/03/1993EP0446225B1 Medicament for treatment of pathological vascular permeability and plasma loss to tissue
03/03/1993EP0211013B1 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms
03/03/1993CN1069522A Intercellular adhesion molecule-3 and its binding ligands
03/02/1993US5191072 Lipid a monosaccharide analogues
03/02/1993US5190935 Vitamin d analogues
03/02/1993US5190589 Compounds and process preparing a substituted or an unsubstituted 4(5)-(ω-aminoalkyl)imidazole
03/02/1993CA1314048C Quinolinylmethoxyphenylsulfonyl-carboxamides as anti-inflammatory/antiallergic agents
03/01/1993CA2076929A1 Substituted mandelic acid derivatives, processes for their preparation and their use in medicaments
02/1993
02/27/1993WO1993004080A1 Pseudopentapeptides with immunomodulating activity
02/27/1993CA2094822A1 Pseudopentapeptides with immunomodulating activity
02/24/1993EP0528452A1 Immunomycin enzymatic and/or microbial methylation products
02/24/1993EP0528337A1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
02/24/1993EP0528172A1 (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists
02/24/1993EP0528007A1 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
02/24/1993EP0527822A1 T-cell suppressor protein
02/24/1993CN1069271A Processes for preparing (1) benzopyrano (4,3-c)-pyrazoles compounds
02/24/1993CA2076553A1 1,7-fused 2-(piperazinoalkyl) indole derivatives, processes and intermediates for their preparation, and pharmaceutical compositions containing them
02/23/1993US5189042 Fluoromacrolides having immunosuppressive activity
02/23/1993CA2076419A1 Fluoromacrolides having immunosuppressive activity
02/18/1993WO1993003146A1 Disease associated b-cell epitopes of tpo and use thereof
02/18/1993WO1993003030A1 Quinoline derivatives as immunostimulants
02/18/1993WO1993003029A1 (-) and (+) 10-(1-azabicyclo[2.2.2.]oct-3-yl-methyl)-10 h-phenothiazine quaternary ammonium derivatives, pharmaceutical compositions containing them and process for their preparation
02/18/1993WO1993003022A1 Compounds and methods for inhibition of hiv and related viruses
02/18/1993WO1993002706A1 Self-adjuvanting peptide vaccine delivery system and production thereof
02/18/1993WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
02/18/1993WO1993002690A1 Diagnosis and treatment of autoimmune diseases
02/18/1993WO1992019613A3 1,2-dithiole-3-thione derivative-based therapeutical compositions
02/18/1993CA2114844A1 (-) and (+) 10-(1-azabicyclo[2.2.2.]oct-3-yl-methyl)-10 h-phenothiazine quaternary ammonium derivatives, pharmaceutical compositions containing them and process for their preparation
02/18/1993CA2114647A1 Diagnosis and treatment of autoimmune diseases
02/18/1993CA2114125A1 Self-adjuvanting peptide vaccine delivery system and production thereof
02/18/1993CA2113280A1 Disease associated b-cell epitopes of tpo and use thereof
02/17/1993EP0527646A1 New compounds named the adenophostins, their preparation and their therapeutic use
02/17/1993EP0527283A1 Food composition
02/17/1993CA2076192A1 Thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
02/17/1993CA2075662A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity
02/16/1993US5187286 Antiinflammatory agents, antiallergens
02/16/1993US5187075 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
02/10/1993EP0526935A1 New microorganism for producing C-31 desmethyl FR-900520 cyclic hemiketal
02/10/1993EP0526934A1 New C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent
02/10/1993EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them
02/10/1993EP0526840A1 Condensed naphthyridine derivatives
02/10/1993EP0526452A1 Hybrid immunoglobulins
02/10/1993CN1068738A Modulation and diagnosis of cytokine dysfunctions
02/10/1993CN1019890C Process for preparation of 4-heterocyclic sulfonyl (or thio-) propyl-oxy-2-hydroxy-3-propyl-hypnone derivatives
02/09/1993US5185442 New diazepines substituted in the 6-position, processes for their preparation and their use as pharmaceutical compositions
02/09/1993US5185441 Polypeptides that bind to CD2, the receptor on the surface of T-cells
02/09/1993US5185377 Applying locally or by inhalation as antiinflammatory agent, antiallergen, bronchodilator, antiasthmatic, antipsoriatic
02/09/1993US5185361 Pharmaceutical compounds